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Edited by Ivan SadowskiAbstract The post-transcriptional control of mRNA levels is a
very powerful mechanism which allows cells to quickly change
the amount of speciﬁc proteins. In this study, we wanted to ana-
lyze whether the Brn-3b transcription factor, essential for the
proper development of mouse retinal ganglion cells, is subjected
to such post-transcriptional regulation. In particular, due to its
conservation amongst diﬀerent species, we wanted to study the
role of its 3 0 untranslated region (3 0UTR).
We show that the 3 0UTR of the Brn-3b mRNA does indeed
contain regulatory sequences that mediate mRNA degradation
upon serum starvation-induced diﬀerentiation of ND7 neuroblas-
toma cells. The speciﬁc region mediating this eﬀect has been
characterized and two diﬀerent microRNAs that potentially reg-
ulate the stability of Brn-3b have been identiﬁed. Moreover we
show that Dicer, one of the key enzymes in the production of
microRNAs, is strongly up-regulated in ND7 cells subjected to
diﬀerentiation.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Brn-3a and Brn-3b, members of the POU IV class of tran-
scription factors are expressed in diﬀerent parts of the central
and peripheral nervous system [1–5]. While mice lacking Brn-
3a die a few days after birth, Brn-3b knock-out mice are viable
but exhibit a speciﬁc and dramatic loss of up to 70% of retinal
ganglion cells (RGC) [6].
Our laboratory has previously shown that when the ND7
neuroblastoma cell line is induced to diﬀerentiate via serum
removal, Brn-3b levels decrease while Brn-3a is increased [7].
The switch between Brn-3a and Brn-3b is extremely important
and allows neuronal cells to activate diﬀerent subset of genes
involved in the cellular routing toward diﬀerentiation (Brn-
3a) [8–12], or proliferation (Brn-3b) [13–16]. A stringent
regulation of Brn-3a and Brn-3b expression is thus essential
for cellular fate and development.
The control of gene expression and overall protein synthesis
is a key process in the metabolism of a cell. Post-transcrip-
tional regulation of mRNA half-life or the regulation of its*Corresponding author. Fax: +44 (0) 20 7905 2301.
E-mail address: m.calissano@ich.ucl.ac.uk (M. Calissano).
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doi:10.1016/j.febslet.2007.04.066translation allows cells to have a very ﬁne and rapid control
over protein synthesis. One of the known mechanisms involved
in the modulation of mRNA stability resides in their 3 0UTR, a
region containing motifs, such as the AU-rich regions (AREs)
which regulate mRNA half-life [17,18].
In this work, we wanted to understand whether Brn-3b
mRNA is subjected to a post-transcriptional regulation in
ND7 cells induced to diﬀerentiate and whether this process is
mediated by its 3 0UTR. This region, in fact, exhibits between
99% and 97% nucleotide identity between human and mouse
and mouse and rhesus monkey, respectively (our unpublished
observation), suggesting a possible important role due to its
conservation.
The data presented herein show that the 3 0UTR of Brn-3b
mediates the degradation of a chimaeric reporter mRNA. This
process is induced by diﬀerentiation stimuli applied to ND7
cells and is likely to be mediated by two diﬀerent microRNAs.
Furthermore we also present evidence that Dicer, one of the
key enzymes in the production of microRNAs, is strongly
up-regulated in ND7 cells induced to diﬀerentiate.2. Materials and methods
2.1. Constructs and vectors
The 3 0UTR of Brn-3b (NM_138944) was ampliﬁed from mouse
genomic DNA with the following primers: 3bUTR-SacI: 5 0gagctctagg-
gacccttctccagggatggccc3 0 and 3bUTR-BamHI: 5 0ggaacccgggtgccagta-
aaacattaaaatcatctc3 0. The resulting circa product was sub-cloned in
the multiple cloning site of pEGFP-C1, downstream of GFP. The
mutants in the microRNA target sequence were obtained via the
QuickChange site directed mutagenesis (Stratagene) following manu-
facturer’s instruction with the following primers: mir-23(upstream)-
Fw-5 0aacaattccggtaaacgggcacccagaccaagccag30, mir-23(upstream)-Rw-
5 0ctggcttggtctgggtgcccgtttaccggaattgtt30, mir-23(downstream)-Fw5 0ga-
gttgatgcttaacgggctatgatagagacatctc30, mir23(downstream)Rw5 0gagat-
gtctctatcatagcccgttaagcatcaactc3 0. mir214-Fw50ggaagttgcgacggttgcgtt-
cactg3 0; mir214-Rw5 0cagtgaacgcaaccgtcgcaacttcc3 0, mir128-Fw5 0cc-
gtgtagaccagatgcgctggcggaagtc3 0; mir128-Rw5 0caagacttccgccagcgcatctg
gtctaca30. The sequential deletion of Brn-3b was performed with the
Bal-31 nuclease (New England Biolabs). All constructs have been
checked by sequencing.
2.2. Cell culture
The neuroblastoma ND7 and the breast cancer MCF-7 cell line were
routinely cultured in DMEM supplemented with 10% Foetal Calf Ser-
um (FCS) at 37C, 95% humidity and 5% CO2. Transfection was per-
formed with GeneJuice (Novagen) according to the manufacturer’s
instruction. SH-SY5Y cells were cultured in 50% MEM, 50% Hams
F12 supplemented with 15% FCS. For all the serum starvation exper-
iments, cells were transfected with the indicated constructs and the fol-
lowing day (day 0) incubated in full medium with or without FCS in
order to induce diﬀerentiation for the indicated days.blished by Elsevier B.V. All rights reserved.
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For mRNA turnover experiment ND7 cells were transfected and
treated as described above. Post-transfection cells (48 h) were treated
with actinomycin D (7.5 lg/ml) for 0, 4 and 8 h [19]. Total RNA, ex-
tracted with Trizol (Invitrogen), has been subjected to real-time RT-
PCR reaction using SYBR I Green technology on the DNA Engine
Opticon System (MJ Research) as previously described [20] with prim-
ers speciﬁc for GFP and for neomycin for normalization purposes.
For Northern blot analysis of small RNA, 30 lg of total RNA were
loaded and run on a 15% polyacrilamide, 7 M UREA gel. The pre-
hybridized membrane was incubated overnight with the appropriate
probes at 42. Probes: U6-gcaggggccatgctaatcttctctgtatcg; mir-214-
ctgcctgtctgtgcctgctgt; mir-128-aaaagagaccggttcac tgtga; mir-23-
ggaaatccctggcaatgtgat, were end labeled with T4 Kinase in the
presence of c32P-ATP. Washes were done at room temperature in 2·
SSC, 0.1% SDS. Membranes were then exposed to a phosphor-imager
screen.
2.4. Western blot
Transfected cells were lysed with RIPA buﬀer (10 mM TRIS pH 7.5,
150 mM NaCl, 0.2% NP-40) supplemented with protease inhibitors
(mini-cocktail, Roche). Membranes were probed with an anti-GFP
antibody (Sigma G-1544), stripped and reprobed with anti-neomycin
antibody (Upstate) for normalization purposes. For Dicer, an anti-Di-
cer antibody (St. Cruz) was used and data normalized with anti-p85
(Upstate). Western blots were scanned and bands analyzed via the
QuantityOne software (Biorad). All experiments were repeated at least
in triplicate. Error bars indicate S.D.Fig. 1. Eﬀect of the 3 0UTR of Brn-3b on the stability of a chimaeric construc
the GFP::3b-30UTR but not with the GFP::UTR control vector and subjec
panel). A typical Western blot is represented in the lower panel. GFP levels i
line (C) serum starved for two days after transfection. (D) Realtime RT-P
treatment for the indicated hours. Data have been normalized with neomyci
repeated at least in triplicate. Error bars indicate S.D.3. Results
3.1. The 3 0UTR of Brn-3b mediates the down-regulation of a
chimaeric reporter construct
The 3 0UTR of Brn-3b was sub-cloned downstream of GFP
in the peGFP expression vector. The peGFP::3bUTR and
the empty peGFP control constructs were transfected into neu-
roblastoma ND7 cells which were then induced to diﬀerentiate
via serum removal and harvested at diﬀerent time points. After
1, 3 or 5 days, GFP levels were assessed by Western blot and
normalized with neomycin, which is expressed from the same
vector. As shown in Fig. 1A serum removal induces a progres-
sive and strong reduction of GFP expression in the construct
containing the 3 0UTR of Brn-3b compared to the ‘empty’ vec-
tor.
In order to conﬁrm the result, we repeated the experiment in
the SH-SY5Y human neuroblastoma and in the MCF-7 hu-
man breast cancer cell line. As shown in Fig. 1B, C, the levels
of the chimaeric mRNA are reduced in the SH-SY5Y but not
in the MCF-7 cell line following serum removal thus suggest-
ing that the chimaeric mRNA is not intrinsically unstable
and that its down-regulation seems to be speciﬁc for neuronal
cell lines and to occur in both human and mouse cells.t. (A) Western blot analysis of GFP levels in ND7 cells transfected with
ted to diﬀerentiation via serum removal for the indicated days (upper
n the SH-SY5Y neuronal cells (B) but not in MCF-7 breast cancer cell
CR analysis of GFP:3b-30UTR mRNA levels after Actinomycin D
n and expressed relative to peGFP control. All experiments have been
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cells transfected with the GFP::3b-3 0UTR is due to increased
degradation of its mRNA or to the inhibition of its translation.
Total RNA extracted from ND7 cells transfected as described
above, serum starved and treated with Actinomycin D, was
subjected to real-time RT-PCR. As shown in Fig. 1D, the lev-
els of the mRNA containing the 3 0UTR of Brn-3b are strongly
and rapidly reduced compared to the control. This suggests
that the observed reduction of GFP at the protein level is
due to the degradation of its mRNA and caused by sequences
contained within the 3 0UTR of Brn-3b. Since both constructs
are under the control of the CMV constitutive promoter, in
fact, no diﬀerential transcriptional regulation can occur, and
post-transcriptional regulation is therefore responsible for re-
duced GFP levels.
3.2. Deletion analysis of the 3 0UTR of Brn-3b
In order to map the region of the 3 0UTR of Brn-3b respon-
sible for this eﬀect, a series of deletion constructs were made
with the Bal-31 nuclease and assessed for their sensitivity to
diﬀerentiation-induced degradation using the assay described
above (Fig. 2A). As shown in Fig. 2B, while the Bal1 deletion
mutant still responds to serum removal like the wild-type, the
Bal4 and Bal7 mutants have lost this ability, suggesting that
they no longer possess the responsive in cis sequence.
All the Bal-31 mutants have been sequenced and analysed
using bioinformatics tools for known sequences that might
mediate mRNA stability at the post-transcriptional level [21]
but no AU-rich or other known sequences were found. The
region deleted in the Bal4 and the Bal7 mutants, though, is
putatively targeted by three diﬀerent microRNAs: mir-23,
mir-128, and mir-214 (http://cbio.mskcc.org/mirnaviewer/),
one of which, mir-23, has two target sites on the 3 0UTR of
Brn-3b (Fig. 2A). These microRNAs putatively bind to highly
conserved (90–100%) sites on the 3 0UTRs of mouse and
human Brn-3b (Fig. 3 right column), suggesting a possible roleFig. 2. Deletion analysis of the 3 0UTR of Brn-3b. (A) Schematic representat
and on the Bal-31 deletion mutants used in this study. The eﬀect of these dele
the average of at least ﬁve independent experiments.due to their evolutionary conservation. Furthermore none of
these putative microRNAs have any matching binding sites
on the 3 0UTR of the closely related Brn-3a transcription factor
suggesting speciﬁcity for Brn-3b (data not shown).
3.3. Mutation of the microRNA sites on the 3 0UTR of Brn-3b
The target sequences of the three candidate microRNAs on
the 3 0UTR of Brn-3b were individually mutagenised by
changing three out of the seven nucleotides, known as the
‘‘seed’’, essential for the binding of the microRNA to its tar-
get sequence (Fig. 3 right-hand column) and the resulting
constructs have been assessed by Western blot. As shown
in Fig. 3 (left column), the mutagenesis of the sites recog-
nized by mir-23 (Fig. 3A, B), mir-214 (Fig. 3C) but not of
mir-128 (Fig. 3D) abolishes the down-regulation of GFP lev-
els. This result is entirely consistent with our observation
that the Bal1 mutant, which lacks the mir-128 binding site,
still responds to serum removal, while Bal4 and Bal7 mu-
tants, lacking the mir-23 and mir-214 binding sites no longer
have this response. The downstream mir-23 target site seems
more important than the upstream one. This is also reﬂected
by the nucleotide similarity between mouse and human and
the overall match of the mir-23 microRNA on its target sites
with mir-23/downstream showing an overall similarity on its
target site which is higher than the one of mir-23/upstream.
Moreover, mir-128, which in our assay does not seem to
have any role in the regulation of the chimaeric construct,
has a very low consensus on its target site on the Brn-3b
3 0UTR, especially at the critical 5 0 ‘‘seed’’ end of the micro-
RNA.
Intriguingly, mutations of the microRNA sites are associ-
ated with reduced GFP levels. This is particularly evident in
the mir23/mir23 double mutant (Fig. 3E), in which both mir-
23 sites have been mutagenised and in the mir23/mir23/
mir214 (Fig. 4F) triple mutant in which the mir-214 site has
been also mutagenised.ion of the microRNA binding sites on the wild-type 3 0UTR of Brn-3b
tions on the production of GFP is graphically represented in (B) and is
Fig. 3. Eﬀect of the mutation on the microRNA binding sites. The alignment of the microRNA binding sites on the 3 0UTR of mouse and human
Brn-3b is represented in the right-hand column. The 5 0 end of the microRNAs (seed) is type faced in gray and the mutations sites introduced in this
study are in ‘bold’ black. The eﬀect of these mutations on GFP levels is displayed on the graph in the left column. The eﬀect of the mir23/mir23
double mutation and the mir-23/mir-23/mir214 triple mutation on the stability of the reporter construct is displayed in panels E and F, respectively.
All experiments have been performed by serum-starving cells for two days after transfection with the indicated constructs.
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Fig. 5. Expression analysis of microRNA and Dicer in ND7 cells. (A)
Northern blot analysis of the levels of the indicated microRNAs in
RNA extracted from ND7 cells grown with or without FCS for two
days and normalized with U6 RNA (bottom panel). (B) Western blot
with an anti-Dicer antibody in ND7 cells grown with or without serum
and (C) graphical representation of the average of three independent
experiments (error bars indicate S.D.).Fig. 4. Eﬀect of the exogenous 3
0UTR of Brn-3b on the levels of
endogenous Brn-3b. Eﬀect of the exogenous chimaeric construct on the
levels of the endogenous Brn-3b (A) and Brn-3a (B) mRNA in ND7
cells induced to diﬀerentiate via serum removal for two days after
transfection.
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3a and Brn-3b levels
We then analysed the eﬀect of the transfection of the
peGFP::3bUTR on the levels of the endogenous Brn-3a and
Brn-3b mRNA in cells induced to diﬀerentiate. As mentioned
in Section 1 in fact, while Brn-3a levels increase, Brn-3b levels
are sharply reduced in ND7 cells induced to diﬀerentiate via
serum removal. Furthermore, although almost identical at
the protein level, Brn-3a and Brn-3b share a very little similar-
ity in their 3 0UTR (data not shown). In ND7 cells transfected
with the peGFP::3bUTR, but not the ‘empty’ GFP vector, the
endogenous Brn-3b mRNA levels are not reduced following
serum removal (Fig. 4a). In the same conditions the levels of
the endogenous Brn-3a transcription factor mRNA increase
during serum removal as expected (Fig. 4b).
3.5. Expression of microRNAs and Dicer in ND7 cells
We next wanted to measure the expression levels of candi-
date microRNAs. Total RNA extracted from ND7 cells grown
in full serum or serum starved, was subjected to Northern blot
analysis. All microRNAs were detected after several days of
exposure and the expression of mir-23, mir-214 but not mir-
128, were increased in ND7 cells subjected to serum removal
(Fig. 5A). We next evaluated whether Dicer, one of the key en-
zymes involved in the production of mature microRNAs, is ex-
pressed and diﬀerentially regulated in ND7 cells subjected to
serum removal. As shown in Fig. 5B, not only Dicer is ex-
pressed in ND7 cells but it is actually strongly up-regulated
following serum removal (Fig. 5C).4. Discussion
In the past years, a new class of molecules named micro-
RNAs (or miRNAs), have been shown to be involved in the
direct regulation of mRNA translation by binding to their
3 0UTR. These 22–23 nucleotide long single stranded RNA
molecules are produced in a wide variety of organisms from
long precursor transcripts [22–24] which, initially folded into
double-stranded RNA molecules, are subjected to a controlled
maturation and shortening process by two proteins with
RNaseIII activity, Drosha in the nucleus and Dicer in the
cytoplasm. One of the two strands of the resulting 22–23
nucleotide long double-stranded RNA, is then incorporated
into the RISC multiprotein (RNA Induced Silencing Com-
plex). Via the speciﬁcity provided by the incorporated micro-
RNA, the complex is able to bind the target mRNA and
directly modulate its degradation or inhibition of translation
[25–27].
The Brn-3b transcription factor, a POU IV-class protein, is
modulated in retinal ganglion cells (RGCs) during develop-
ment. By using diﬀerent approaches we have established that
its 3 0UTR is involved in the modulation of a reporter mRNA
via the targeting of microRNAs. The individual mutagenesis of
these microRNA binding sites allowed us to determine that
mir-23 and mir-214 but not mir-128 are likely to be involved
in the down-regulation of Brn-3b upon serum removal in
ND7 cells. Furthermore the downstream mir-23 binding site
is part of a consensus sequence termed ‘K-box’ (cUGU-
GAUa). This was originally identiﬁed in the 3 0UTR of Notch
pathway target genes such as basic helix–loop–helix repressors
and members of the Bearded family proteins [28]. It is thus pos-
sible that Brn-3b is a member of the proteins targeted by the
Notch pathway during RGCs development.
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the 3 0UTR of Brn-3b seems suﬃcient to alleviate serum starva-
tion-induced down-regulation of GFP::3bUTR, these mutants
display overall lower GFP levels compared to the ‘wild-type’
GFP vector. Our data suggests that, besides a role in the
down-regulation of the GFP::3bUTR chimaeric construct ex-
erted by microRNAs as a response to a speciﬁc stimulus, the
mutagenesis of the 3 0UTR of Brn-3b seems to be causing per
se its increased degradation. This is especially evident in the
mir-23/mir-23 double mutant (Fig. 3E) or in the mir-23/mir-
23/mir-214 triple mutant (Fig. 3F) in which the overall levels
of GFP, instead of increasing due to the elimination of pro-
gressively more microRNA binding sites, are instead lower
than their wild-type counterpart. These data suggest that the
down-regulation of the diﬀerent mutant GFP::3bUTR con-
structs is a process which possibly involves two separate mech-
anisms. One, mediated by microRNAs, seems to be involved in
the speciﬁc down-regulation of the GFP::3bUTR mRNA as
triggered by serum removal; the other instead seems to be
causing a microRNA- and diﬀerentiation stimuli-independent
degradation of the chimaeric mRNA. Although at the present
time the mechanism involved in the latter phenomenon is not
clear, we might speculate that, as described previously
[29,30], the chimaeric mRNA harbouring a mutated 3 0UTR
has an altered secondary structure and is therefore degraded.
The role of the 3 0UTR of Brn-3b in the degradation of the
chimaeric GFP mRNA has also been indirectly conﬁrmed by
evaluating its eﬀect on the modulation of the endogenous
Brn-3b transcription factor. In comparison to cells transfected
with the GFP empty control vector, the endogenous Brn-3b
mRNA is not down-regulated in cells transfected with the
pGFP::3bUTR reporter construct. The 3 0UTR of the exoge-
nous construct, in fact, is likely to be titrating the microRNAs
involved in the down-regulation of Brn-3b. This is also con-
ﬁrmed by the lack of any eﬀect on the closely related Brn-3a
transcription factor which is known to be up-regulated in dif-
ferentiating ND7 cells. Since the 3 0UTR of Brn-3a and Brn-3b
do not have any similarity, these data conﬁrm the speciﬁcity of
the observed eﬀect as mediated by the 3 0UTR of Brn-3b. This
eﬀect could be also experimentally used to speciﬁcally block
the down-regulation of Brn-3b or any other mRNA which
are modulated via their 3 0UTR and control their levels
in vitro at a post-transcriptional level.
The analysis of microRNA expression levels has allowed us
to show that mir-23, mir-214 and mir-128 are expressed in our
system and that mir-23 and mir-214 are up-regulated in ND7
cells subjected to serum removal. Furthermore we have found
that Dicer, involved in the production of mature microRNAs,
is also up-regulated in ND7 cells subjected to diﬀerentiation.
To our knowledge this is the ﬁrst time that Dicer expression
has been shown to be altered by serum removal diﬀerentiation
stimuli in neuroblastoma cells.
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